Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Alzheimer's Disease

Free Subscription 02.05.2022 3 Acta Neuropathol 1 Alzheimer Dis Assoc Disord 8 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 1 BMC Geriatr 1 Dement Geriatr Cogn Disord 1 Exp Gerontol 14 J Alzheimers Dis 1 J Am Geriatr Soc 3 J Biol Chem 2 J Neurochem 1 J Neurol Neurosurg Psychiatry 2 JAMA Intern Med 1 Lancet 3 Neurobiol Aging 1 Neurobiol Dis 1 Neurochem Res 1 Neurologia (Engl Ed) 6 Neurology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. CYKOWSKI MD, Arumanayagam AS, Powell SZ, Rivera AL, et al
   Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies.
   Acta Neuropathol. 2022;143:531-545.
   PubMed         Abstract available
   
   
2. CHEN S, Acosta D, Li L, Liang J, et al
   Wolframin is a novel regulator of tau pathology and neurodegeneration.
   Acta Neuropathol. 2022;143:547-569.
   PubMed         Abstract available
   
   
3. JIN Y, Li F, Sonoustoun B, Kondru NC, et al
   APOE4 exacerbates alpha-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
   Acta Neuropathol. 2022 Apr 26. pii: 10.1007/s00401-022-02421.
   PubMed         Abstract available
   
   

   
   Alzheimer Dis Assoc Disord

4. HAKHU NR, Gillen DL, Grill JD
   Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial.
   Alzheimer Dis Assoc Disord. 2022 Apr 29. pii: 00002093-990000000-00006.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

5. PARK SY, Setiawan VW, White LR, Wu AH, et al
   Modifying effects of race and ethnicity and APOE on the association of physical activity with risk of Alzheimer's disease and related dementias.
   Alzheimers Dement. 2022 Apr 27. doi: 10.1002/alz.12677.
   PubMed         Abstract available
   
   
6. PETERSON A, Clapp J, Largent EA, Harkins K, et al
   What is paradoxical lucidity? The answer begins with its definition.
   Alzheimers Dement. 2022;18:513-521.
   PubMed         Abstract available
   
   
7. BARIL AA, Beiser AS, Sanchez E, Mysliwiec V, et al
   Insomnia symptom severity and cognitive performance: Moderating role of APOE genotype.
   Alzheimers Dement. 2022;18:408-421.
   PubMed         Abstract available
   
   
8. O'BRYANT S, Petersen M, Hall J, Johnson L, et al
   Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.
   Alzheimers Dement. 2022;18:240-250.
   PubMed         Abstract available
   
   
9. CHANG R, Trushina E, Zhu K, Zaidi SSA, et al
   Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.
   Alzheimers Dement. 2022 Apr 28. doi: 10.1002/alz.12675.
   PubMed         Abstract available
   
   
10. SCHMUTTE T, Olfson M, Maust DT, Xie M, et al
    Suicide risk in first year after dementia diagnosis in older adults.
    Alzheimers Dement. 2022;18:262-271.
    PubMed         Abstract available
    
    
11. KREISL WC, Lao PJ, Johnson A, Tomljanovic Z, et al
    Patterns of tau pathology identified with (18) F-MK-6240 PET imaging.
    Alzheimers Dement. 2022;18:272-282.
    PubMed         Abstract available
    
    
12. NAUEN DW, Troncoso JC
    Amyloid-beta is present in human lymph nodes and greatly enriched in those of the cervical region.
    Alzheimers Dement. 2022;18:205-210.
    PubMed         Abstract available
    
    

    
    Am J Alzheimers Dis Other Demen

13. MONTESINOS R, Parodi JF, Diaz MM, Herrera-Perez E, et al
    Validation of Picture Free and Cued Selective Reminding Test for Illiteracy in Lima, Peru.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221094396.
    PubMed         Abstract available
    
    

    
    BMC Geriatr

14. YOON B, Kim HJ
    Patterns of dementia treatment in older adults with Parkinson's disease using nationwide medical claims data.
    BMC Geriatr. 2022;22:353.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

15. DUFF K, Wan L, Levine DA, Giordani B, et al
    The Quick Dementia Rating System and Its Relationship to Biomarkers of Alzheimer's Disease and Neuropsychological Performance.
    Dement Geriatr Cogn Disord. 2022 Apr 27:1-7. doi: 10.1159/000524548.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

16. BAZRGAR M, Khodabakhsh P, Dargahi L, Mohagheghi F, et al
    MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid betaeta oligomer induced Alzheimer's like rat model.
    Exp Gerontol. 2022;164:111812.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

17. WONG HY, Zhong H, Zhong M, Zhou X, et al
    Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215312. doi: 10.3233/JAD-215312.
    PubMed         Abstract available
    
    
18. KETCHUM FB, Erickson CM, Chin NA, Gleason CE, et al
    What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215521. doi: 10.3233/JAD-215521.
    PubMed         Abstract available
    
    
19. HUTTEN DR, Bos JHJ, de Vos S, Hak E, et al
    Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study.
    J Alzheimers Dis. 2022 Apr 18. pii: JAD215057. doi: 10.3233/JAD-215057.
    PubMed         Abstract available
    
    
20. O'BRYANT SE, Petersen M, Hall J, Johnson L, et al
    Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.
    J Alzheimers Dis. 2022;86:1745-1750.
    PubMed         Abstract available
    
    
21. HU H, Fu JT, Bi YL, Ma YH, et al
    Tau Pathologies Mediate the Association of Cigarette Smoking with Cognitive Impairment in Older Adults Without Dementia: The CABLE Study.
    J Alzheimers Dis. 2022;86:1849-1859.
    PubMed         Abstract available
    
    
22. ZHANG L, Fu Y, Zhao Z, Cong Z, et al
    Analysis of Hippocampus Evolution Patterns and Prediction of Conversion in Mild Cognitive Impairment Using Multivariate Morphometry Statistics.
    J Alzheimers Dis. 2022;86:1695-1710.
    PubMed         Abstract available
    
    
23. PARKER AF, Ohlhauser L, Scarapicchia V, Smart CM, et al
    A Systematic Review of Neuroimaging Studies Comparing Individuals with Subjective Cognitive Decline to Healthy Controls.
    J Alzheimers Dis. 2022;86:1545-1567.
    PubMed         Abstract available
    
    
24. SANDBERG AA, Manning E, Wilkins HM, Mazzarino R, et al
    Mitochondrial Targeting of Amyloid-beta Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-beta.
    J Alzheimers Dis. 2022;86:1727-1744.
    PubMed         Abstract available
    
    
25. LI C, Liu M, Xia J, Mei L, et al
    Predicting Brain Amyloid-beta PET Grades with Graph Convolutional Networks Based on Functional MRI and Multi-Level Functional Connectivity.
    J Alzheimers Dis. 2022;86:1679-1693.
    PubMed         Abstract available
    
    
26. KONCZ R, Wen W, Makkar SR, Lam BCP, et al
    The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults.
    J Alzheimers Dis. 2022;86:1617-1628.
    PubMed         Abstract available
    
    
27. CATO S, Ramer S, Hajjar I, Kulshreshtha A, et al
    Alzheimer's Disease Mortality as a Function of Urbanization Level: 1999-2019.
    J Alzheimers Dis. 2022 Apr 22. pii: JAD215586. doi: 10.3233/JAD-215586.
    PubMed         Abstract available
    
    
28. MIRABNAHRAZAM G, Ma D, Lee S, Popuri K, et al
    Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220021. doi: 10.3233/JAD-220021.
    PubMed         Abstract available
    
    
29. RAMSDEN CE, Keyes GS, Calzada E, Horowitz MS, et al
    Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220071. doi: 10.3233/JAD-220071.
    PubMed         Abstract available
    
    
30. RAHMANI F, Wang Q, McKay NS, Keefe S, et al
    Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.
    J Alzheimers Dis. 2022;86:1831-1848.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

31. MEYERS DJ, Rivera-Hernandez M, Kim D, Keohane LM, et al
    Comparing the care experiences of Medicare Advantage beneficiaries with and without Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Apr 29. doi: 10.1111/jgs.17817.
    PubMed         Abstract available
    
    

    
    J Biol Chem

32. ACOSTA DM, Mancinelli C, Bracken C, Eliezer D, et al
    Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.
    J Biol Chem. 2022;298:101442.
    PubMed         Abstract available
    
    
33. SHOBO A, James N, Dai D, Rontgen A, et al
    The amyloid-beta1-42-oligomer interacting peptide D-AIP possesses favorable biostability, pharmacokinetics, and brain region distribution.
    J Biol Chem. 2022;298:101483.
    PubMed         Abstract available
    
    
34. AHMED R, Huang J, Lifshitz R, Martinez Pomier K, et al
    Structural determinants of the interactions of catechins with Abeta oligomers and lipid membranes.
    J Biol Chem. 2022;298:101502.
    PubMed         Abstract available
    
    

    
    J Neurochem

35. KLAFKI HW, Wirths O, Mollenhauer B, Liepold T, et al
    Detection and quantification of Abeta-3-40 (APP669-711) in cerebrospinal fluid.
    J Neurochem. 2022;160:578-589.
    PubMed         Abstract available
    
    
36. YU ZY, Yi X, Wang YR, Zeng GH, et al
    Inhibiting alpha1-adrenergic receptor signaling pathway ameliorates AD-type pathologies and behavioral deficits in APPswe/PS1 mouse model.
    J Neurochem. 2022;161:293-307.
    PubMed         Abstract available
    
    

    
    J Neurol Neurosurg Psychiatry

37. OECKL P, Anderl-Straub S, Von Arnim CAF, Baldeiras I, et al
    Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion.
    J Neurol Neurosurg Psychiatry. 2022 Apr 27. pii: jnnp-2021-328547.
    PubMed         Abstract available
    
    

    
    JAMA Intern Med

38. PALAN LOPEZ R, Hendricksen M, McCarthy EP, Mazor KM, et al
    Association of Nursing Home Organizational Culture and Staff Perspectives With Variability in Advanced Dementia Care: The ADVANCE Study.
    JAMA Intern Med. 2022;182:313-323.
    PubMed         Abstract available
    
    
39. LEE CS, Gibbons LE, Lee AY, Yanagihara RT, et al
    Association Between Cataract Extraction and Development of Dementia.
    JAMA Intern Med. 2022;182:134-141.
    PubMed         Abstract available
    
    

    
    Lancet

40. JAFFE S
    Medicare covers new Alzheimer's drug, but there is a catch.
    Lancet. 2022;399:1585.
    PubMed        
    
    

    
    Neurobiol Aging

41. GUISLE I, Canet G, Petry S, Fereydouni-Forouzandeh P, et al
    Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia.
    Neurobiol Aging. 2022;113:118-130.
    PubMed         Abstract available
    
    
42. MORTAMAIS M, Gutierrez LA, Balem M, Bars EL, et al
    Sulcal morphology as cognitive decline predictor in older adults with memory complaints.
    Neurobiol Aging. 2022;113:84-94.
    PubMed         Abstract available
    
    
43. HULSHOF LA, Frajmund LA, van Nuijs D, van der Heijden DCN, et al
    Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age.
    Neurobiol Aging. 2022;113:28-38.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

44. PURIS E, Auriola S, Petralla S, Hartman R, et al
    Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model.
    Neurobiol Dis. 2022 Apr 23:105741. doi: 10.1016/j.nbd.2022.105741.
    PubMed         Abstract available
    
    

    
    Neurochem Res

45. GHOLIPOUR P, Komaki A, Parsa H, Ramezani M, et al
    Therapeutic Effects of High-Intensity Interval Training Exercise Alone and Its Combination with Ecdysterone Against Amyloid Beta-Induced Rat Model of Alzheimer's Disease: A Behavioral, Biochemical, and Histological Study.
    Neurochem Res. 2022 Apr 29. pii: 10.1007/s11064-022-03603.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

46. RODRIGO-HERRERO S, Mendez-Barrio C, Bernal Sanchez-Arjona M, de Miguel-Tristancho M, et al
    Preliminary analysis of a shortened picture version of the Free and Cued Selective Reminding Test.
    Neurologia (Engl Ed). 2022;37:192-198.
    PubMed         Abstract available
    
    

    
    Neurology

47. BEAUDIN AE, McCreary CR, Mazerolle EL, Gee M, et al
    Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy.
    Neurology. 2022;98:e1716-e1728.
    PubMed         Abstract available
    
    
48. HESHMATOLLAH A, Fani L, Koudstaal PJ, Ghanbari M, et al
    Plasma Amyloid Beta, Total-Tau and Neurofilament Light Chain Levels and the Risk of Stroke: A Prospective Population-Based Study.
    Neurology. 2022 Mar 1. pii: WNL.0000000000200004.
    PubMed         Abstract available
    
    
49. COLLIJ LE, Salvado G, Wottschel V, Mastenbroek SE, et al
    Spatial-Temporal Patterns of beta-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis.
    Neurology. 2022;98:e1692-e1703.
    PubMed         Abstract available
    
    
50. VOGEL JW, Tosun D
    Multiple Cortical to Striatal Accumulation Trajectories of beta-Amyloid: Do All Roads Lead to Rome?
    Neurology. 2022;98:695-696.
    PubMed        
    
    
51. ARANHA MR, Fortea J, Carmona-Iragui M
    Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease.
    Neurology. 2022 Apr 25. pii: WNL.0000000000200704.
    PubMed        
    
    
52. WHITWELL J, Martin PR, Graff-Radford J, Machulda M, et al
    Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200336.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: